Retatrutide vs Tirzepatide: Triple Agonist vs Dual Agonist Comparison for Metabolic Research Retatrutide, a first-in-class triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors, demonstrates unprecedented weight loss efficacy in clinical trialsup to 24.2% body weight reduction at 48 weeks
If you've missed a scheduled injection, understanding the right next steps helps you get back on track without disrupting your treatment timeline
Treat areas like abs, thighs, & arms
poor sleep independently suppresses testosterone Stress management: Chronic cortisol elevation impairs testosterone production Limiting alcohol: Excessive alcohol consumption suppresses testosterone and impairs liver metabolism Side Effects and Safety Considerations Tirzepatide Side Effects The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, constipation, and decreased appetite
Exclusion criteria included previous VTE, using a DOAC or had AF, as well as if patients were on both medications